Article
Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection
1 Mar 2017
Abstract excerpt
Recent insights into the mechanisms by which Mycobacterium tuberculosis , the etiologic agent of human tuberculosis, is recognized by cytosolic nucleotide sensors have opened new avenues for rational vaccine design. The only licensed anti-tuberculosis vaccine, Mycobacterium bovis BCG, provides limited protection. A feature of BCG is the partial deletion of the ESX-1 type VII secretion system, which governs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
